EPIDEMIOLOGICAL FEATURES OF CORONARY ARTERY BYPASS GRAFTING IN CONTEMPORARY CARDIAC SURGERY PRACTICE

Authors

  • Zinatulina D.R., Mukhamedova B.F., Koyirov A.K., Abdurakhmanov A.A., Obeid M.A. Republican Research Centre of Emergency Medicine Author

Keywords:

coronary artery bypass grafting, coronary heart disease, coronary revascularization, epidemiology, multivessel disease, diabetes mellitus, cardiac surgery.

Abstract

Coronary artery bypass grafting is one of the main methods of surgical myocardial revascularization in patients with coronary heart disease and remains highly important in contemporary cardiac surgery. Despite the widespread development of percutaneous coronary interventions and improvements in pharmacological therapy, coronary artery bypass grafting remains the method of choice in selected patients with multivessel coronary artery disease, left main coronary artery disease, diabetes mellitus, and complex coronary anatomy. In recent years, the epidemiology of coronary artery bypass grafting has changed under the influence of population aging, the increasing prevalence of diabetes mellitus, obesity, chronic kidney disease, and changes in approaches to selecting the method of revascularization. This article discusses current epidemiological aspects of coronary artery bypass grafting, its place in the treatment of coronary heart disease, age- and sex-related characteristics of patients, the influence of comorbidity, and contemporary trends in surgical revascularization.

References

1.Roth G.A., Mensah G.A., Johnson C.O., et al. Global Burden of Cardiovascular Diseases and Risk Factors, 1990–2019. Journal of the American College of Cardiology. 2020;76(25):2982–3021.

2.Timmis A., Vardas P., Townsend N., et al. European Society of Cardiology: cardiovascular disease statistics 2021. European Heart Journal - Quality of Care and Clinical Outcomes. 2022;8(4):377–382.

3.Lawton J.S., Tamis-Holland J.E., Bangalore S., et al. 2021 ACC/AHA/SCAI Guideline for Coronary Artery Revascularization. Circulation. 2022;145: e18–e114.

4.Neumann F.J., Sousa-Uva M., Ahlsson A., et al. 2018 ESC/EACTS Guidelines on myocardial revascularization. European Heart Journal. 2019;40(2):87–165.

5.Vrints C., Andreotti F., Koskinas K.C., et al. 2024 ESC Guidelines for the management of chronic coronary syndromes. European Heart Journal. 2024.

6.Farkouh M.E., Domanski M., Dangas G.D., et al. Long-term survival following multivessel revascularization in patients with diabetes: FREEDOM Follow-On Study. Journal of the American College of Cardiology. 2019;73(6):629–638.

7.Thuijs D.J.F.M., Kappetein A.P., Serruys P.W., et al. Percutaneous coronary intervention versus coronary artery bypass grafting in patients with three-vessel or left main coronary artery disease: 10-year follow-up of the SYNTAX trial. The Lancet. 2019;394(10206):1325–1334.

8.Bowdish M.E., D’Agostino R.S., Thourani V.H., et al. The Society of Thoracic Surgeons Adult Cardiac Surgery Database: 2021 update on outcomes and research. The Annals of Thoracic Surgery. 2021;111(6):1770–1780.

9.von Ballmoos M.C.W., et al. The Society of Thoracic Surgeons Adult Cardiac Surgery Database: 2023 update on procedure data and research. The Annals of Thoracic Surgery. 2024.

10.Alexander K.P., Anstrom K.J., Muhlbaier L.H., et al. Outcomes of cardiac surgery in older patients and the importance of frailty assessment. Journal of the American Geriatrics Society. 2016.

11.Afilalo J., Lauck S., Kim D.H., et al. Frailty in older adults undergoing aortic valve replacement and coronary artery bypass grafting. Journal of the American College of Cardiology. 2017;70(6):689–700.

12.Gaudino M., Di Franco A., Alexander J.H., et al. Sex differences in outcomes after coronary artery bypass grafting: a pooled analysis of individual patient data. JAMA Surgery. 2021;156(2): e205559.

13.Gaudino M., Benedetto U., Fremes S., et al. Radial-artery or saphenous-vein grafts in coronary-artery bypass surgery. New England Journal of Medicine. 2018; 378:2069–2077.

14.Bangalore S., Guo Y., Samadashvili Z., et al. Revascularization in patients with multivessel coronary artery disease and diabetes mellitus. Circulation: Cardiovascular Interventions. 2015;8: e002626.

15.Maron D.J., Hochman J.S., Reynolds H.R., et al. Initial invasive or conservative strategy for stable coronary disease. New England Journal of Medicine. 2020; 382:1395–1407.

Downloads

Published

2026-05-23